NorthWest Biotherapeutics Inc (NWBO)

[DJknows]

They put out a 70-page report on it:

https://www.webdisclosure.com/press-release/jaguar-health-inc-etr-original-research-jaguar-health-inc-von-first-berlin-equity-research-gmbh-buy-GBvQwW7AuI2

Open the above and hit the link near the bottom of the page where it says

"You can download the research here: NWBO_US-2026-03-24_EN"

Here are some of their introductory headlines on the first two pages:

DCVax-L positions Northwest for the first meaningful therapeutic advance in GBM in over two decades

Clinically meaningful overall survival (OS) outcomes with long-term benefit

Evolving UK regulatory framework supports the use of external control data in rare diseases

First potential approval in the UK in 2026, with commercial launch targeted for 2027

Large commercial opportunity in GBM – Sales potential of ~USD 2.7bn

Pipeline breadth beyond GBM, with valuation upside embedded

We initiate coverage with a price target of USD 1.00 and a Buy recommendation